# CSL Behring

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/csl-behring/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company |
| OpenAlex ID | https://openalex.org/F4320310420 |
| ROR ID | https://ror.org/01jxhxv92 |
| Works | 6,350 |

## Funder papers

- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial](https://scholariq.org/papers/long-term-kidney-outcomes-of-semaglutide-in-obesity-and-cardiovascular-disease/)
- [The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study](https://scholariq.org/papers/the-effect-of-intravenous-ferric-carboxymaltose-on-health-related-quality-of/)
- [A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease](https://scholariq.org/papers/a-comparative-post-hoc-analysis-of-finerenone-and-spironolactone-in-resistant/)
- [Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial](https://scholariq.org/papers/effect-of-empagliflozin-on-heart-failure-outcomes-after-acute-myocardial/)
- [Analysis of Worsening Heart Failure Events in an Integrated Health Care System](https://scholariq.org/papers/analysis-of-worsening-heart-failure-events-in-an-integrated-health-care-system/)
- [Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery](https://scholariq.org/papers/levosimendan-in-patients-with-reduced-left-ventricular-function-undergoing/)
- [Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial](https://scholariq.org/papers/spironolactone-versus-placebo-in-patients-undergoing-maintenance-dialysis/)
- [Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial](https://scholariq.org/papers/impact-of-oral-semaglutide-on-kidney-outcomes-in-people-with-type-2-diabetes/)
- [Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System](https://scholariq.org/papers/sex-based-differences-in-the-epidemiology-clinical-characteristics-and-outcomes/)
- [Health Care Resource Utilization and Associated Costs Across Proteinuria and Declining Kidney Function in Patients With IgA Nephropathy: A Retrospective Study in Three European Countries](https://scholariq.org/papers/health-care-resource-utilization-and-associated-costs-across-proteinuria-and/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.